• Title of article

    IPCS Conceptual Framework for Evaluating a Mode of Action for Chemical Carcinogenesis

  • Author/Authors

    Cindy Sonich-Mullin، نويسنده , , C. and Fielder، نويسنده , , R. and Wiltse، نويسنده , , J. and Baetcke، نويسنده , , K. and Dempsey، نويسنده , , J. and Fenner-Crisp، نويسنده , , P. and Grant، نويسنده , , D. J. Hartley، نويسنده , , M. van Knaap ، نويسنده , , A. and Kroese، نويسنده , , D. and Mangelsdorf، نويسنده , , I. and Meek، نويسنده , , E. W. Rice، نويسنده , , J.M. and Younes، نويسنده , , M.، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2001
  • Pages
    7
  • From page
    146
  • To page
    152
  • Abstract
    The International Programme on Chemical Safety (IPCS) is leading an activity to harmonize approaches to cancer risk assessment as a part of its larger project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals. Through a series of workshops and the evaluation of case studies, a number of key components of risk assessments relating to harmonization were identified: transparency, terminology, weight of evidence, flexibility, and accessibility/communication. A major impediment to harmonization identified in the consideration of weight of evidence was the evaluation of mode of action. To address this need, a conceptual framework was developed, based on the general principles involved in considering the chemical induction of a specific tumor in animals. This is based partly on the Bradford Hill criteria for causality as modified by Faustman et al. (1997) for developmental toxicity. The framework is described in this paper followed by a worked example. It is recognized that the framework addresses only one stage in the overall characterization of hazard to humans of chemical carcinogens. Another important but separate step is the assessment of relevance to humans. This is a priority area for future work in this project.
  • Journal title
    Regulatory Toxicology and Pharmacology
  • Serial Year
    2001
  • Journal title
    Regulatory Toxicology and Pharmacology
  • Record number

    1487066